Safe Orthopaedics’ Products Adopted by the Texas Back Institute, a World-Renowned Hospital in the United States (press release)
SAFE ORTHOPAEDICS (Paris:SAFOR)(FR0012452746 – SAFOR), a company developing and marketing an innovative range of sterile implants combined with their single-use surgical instruments, announces today that the first surgery using its products has taken place at the Texas Back Institute, a leader in spinal surgery.
The first surgery was performed by Dr. Richard Guyer (one of the Texas Back Institute’s founding partners), assisted by Dr. Jack Zigler. They successfully performed a minimally invasive lumbar fusion using Safe Orthopaedics’ single-use instruments. Dr. Guyer is certified by the American Board of Orthopedic Surgery and is a past president of the NASS (North American Spine Society). Dr. Zigler is also Board Certified and is a past president of the American Spinal Injury Association (ASIA).
Dr. Guyer said: “The surgery went flawlessly. I was particularly impressed by Safe Orthopaedics’ extremely smart innovation, which helps in securing patient safety. The operating room staff also really appreciated the product’s ease of use and the substantial time savings it generates.”
Dr. Zigler added:“For mini-invasive screw implantation, the system is as user-friendly as any of the standard systems we use. The learning curve is minimal, limited to 1or 2 cases for most, if not all, surgeons.”
The Texas Back Institute, founded more than 35 years ago, has a worldwide reputation in spinal surgery. The Institute is very active in leading or participating in FDA trials and is dedicated to training spine surgeons. The Institute is employing an expert medical team and has pioneered many of the breakthrough technologies in the United States.
Yves Vignancour, Chief Executive Officer of Safe Orthopaedics, declared: “It is an honor to work with the Texas Back Institute, an internationally renowned center that trains surgeons from all around the world. The success of the initial back surgery performed by Dr. Guyer and Dr. Zigler illustrates the growing interest in the United States in our single-use products and demonstrates their quality and suitability.”
Next financial press release:
Revenue for the 2nd quarter of 2015 will be published on Wednesday July 15, 2015 (after market)
About Safe Orthopaedics
Founded in 2010, Safe Orthopaedics is a French medical technology company that develops and markets an innovative range of sterile implants and associated single-use surgical instruments, with the aim of facilitating safer, optimized and lower-cost spinal surgery. By avoiding the reuse of surgical instruments, Safe Orthopaedics reduces the risk of infection, avoids the cumbersome and unreliable logistics of instrument sterilization, and limits hospital costs. Protected by 17 patent families, the company’s CE-marked and FDA-approved SteriSpineTM kits are already being marketed in 12 countries, in Europe and the United States. They are being rapidly adopted by surgeons throughout the world, with nearly 1,000 procedures performed in 2014 and 550 in the first quarter of 2015 alone. The company is based at Eragny-sur-Oise (France), and has 33 employees and a US subsidiary.
For more information, visit: www.SafeOrtho.com
Safe Orthopaedics
Yves Vignancour
CEO
Elvire Huisse
CFO
Tel.: +33 (0)1 34 21 50 00
investors@safeorthopaedics.com
or
NewCap
Julien Perez / Valentine Brouchot
Investor Relations
or
Nicolas Merigeau
Press Relations
Tel.: +33 (0)1 44 71 94 94
SafeOrtho@newcap.fr